Skip to main content
Equibles

Nuveen, LLC

Position in AKTS — Aktis Oncology, Inc.

CIK 1871926 CHARLOTTE, NC
Back to AKTS Full portfolio

Position in AKTS

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,605,569
+$1,167,837 QoQ
Shares Held
49,816
+103.6% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 114 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKTS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Nuveen, LLC holds $4,966,990,470 across 286 Biotechnology names. AKTS ranks #168 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 2,019,974 $1,259,534,587
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,081,685 $537,305,388
3 EXEL
Exelixis, Inc.
 3,276,984 $178,300,697
4 ALNY
Alnylam Pharmaceuticals, Inc.
 315,630 $95,014,096
5 TGTX
Tg Therapeutics, Inc.
 1,625,876 $89,325,625
6 RVMD
Revolution Medicines, Inc.
 475,231 $89,001,259
7 JAZZ
Jazz Pharmaceuticals plc
 365,405 $88,051,641
8 ROIV
Roivant Sciences Ltd.
 1,970,504 $69,736,134

All Filings in AKTS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,605,569 49,816
2026-03-31 $437,732 24,468